Jan 17, 2012 ... Defendant: Takeda Pharmaceutical Co Ltd, Takeda Pharmaceuticals North America Inc, Takeda Pharmaceuticals L L C, Takeda Pharmaceuticals International Inc, Takeda Global Research & Development Center Inc, Takeda San Diego Inc, Takeda California Inc and Takeda Pharmaceuticals U S A Inc.
Feb 7, 2018 ... Wednesday, February 07, 2018. 2, 2 service Summons Issued Wed 4:44 PM SUMMONS ISSUED as to ABBOTT LABORATORIES, ASTRA US HOLDING CORPORATION, ASTRA USA LLC, ASTRAZENECA AB, ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA PLC, KBI SUB ...
Jul 17, 2015 ... LOS ANGELES — (Mealey's) A California appeals court panel on July 16 reinstated a $6.5 million Actos bladder cancer verdict, finding that the trial court erred in excluding the plaintiffs' causation expert in a post-verdict ruling (Nancy Cooper, et al. v. Takeda Pharmaceuticals America, Inc., et al., No.
Apr 21, 2014 ... Estate of William Whitlatch vs. Takeda Pharmaceuticals America, Inc., et al. • The Court will conduct a renewed jury instruction conference and renewed evidentiary hearing regarding Dr. Parisian on April 14, 2014. • Jury selection will take place on April 16 and 17, 2014. • Opening statements are April 21, ...
Jul 31, 2014 ... Luitpold Pharmaceuticals, Inc. v. Apotex Corp. et al. 2:14-cv-04409; filed July 11, 2014 in the District Court of New Jersey. • Plaintiff: Luitpold Pharmaceuticals, Inc. • Defendants: Apotex Corp.; Apotex Inc.; Recordati Ireland Ltd. Infringement of U.S. Patent No. 6,333,044 ("Therapeutic compositions for ...
Jun 2, 2014 ... Allen v. Takeda Pharmaceuticals International, Inc., et al, Civil Action No. 6:]2-cv- 00064-. 11 Upon review of the “filed” ruling, the Court noted the ruling which was ultimately filed, inexplicable, ... in the United States will either be identiﬁed by their acronyms (“TPNA” for Takeda Pharmaceuticals North America.
Dec 20, 2012 ... Blaise Pascal, Pascal's Pensées 104 (E.P. Dutton & Co., Inc.1958) (1670). But under the Age Discrimination in Employment Act, 29 U.S.C. § 621 et seq., a contradiction of the employer's proffered reason for the termination of an employee is sometimes enough, when combined with other evidence, to allow ...
Actavis Laboratories FL, Inc., No. 11-914 (D. Del.). Represented Actavis in a patent infringement case concerning Actavis's ANDA for a generic version of Embeda® (morphine sulfate and naltrexone hydrochloride). Takeda Pharmaceutical Co., Ltd. et al. v. Handa Pharmaceuticals, LLC and Par Pharmaceutical, Inc., No.
ProPublica has compiled the disclosed payments from pharma companies to doctors and other health care providers. Search for your doctor in our interactive database.